Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam for Bile Acid Malabsorption in Crohn's Disease
NCT01203254Phase 4Terminated
- Sponsor
- Florian Beigel
- Start
- Oct 2010
- Primary completion
- Mar 2013
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of colesevelam in bile acid malabsorption (BAM), sponsored by Florian Beigel. Started Oct 2010; status: terminated.
02
Drugs
colesevelam
03
Conditions
bile acid malabsorption (BAM)
Beyond the preview
Go deeper on NCT01203254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203254.